Axon Enterprise, Inc. (NASDAQ: AXON) is the company behind TASER devices, police body cameras, and the Evidence.com cloud platform
I bought $100 worth of Axon Enterprise, Inc. (AXON) — which, given the share price, is basically a molecular fragment of a share.

HERE MY BUY ORDER:

12/05/2025 14:09:15

$100.00

AXON

Market

Quantity 0.18138

Bought @ 551.3199

Why? Because of one simple, verifiable fact:

The word “TASER” legally belongs to Axon Enterprise.

And that tiny word might have big global value.

---

🔒 TASER: A Trademark With Serious Power

Let’s start with the foundation.

• The TASER name is a registered trademark of Axon. (Multiple registrations, including the long-standing one visible on Justia.)
• Axon itself explicitly states that “TASER and Axon Yellow are trademarks of Axon Enterprise, Inc., some of which are registered in the US and other countries.”
• When the company changed its name from TASER International, Inc. to Axon in 2017, the TASER name remained the core trademark and product brand.

In other words:
Axon doesn’t just sell TASER devices — Axon owns the TASER name.
Legally. Globally. Strategically.

This is not a generic term; it’s intellectual property with decades of recognition.

And that matters.

---

🌍 The International Upside: Most of the World Still Isn’t Buying TASERs

Here’s the part that made me tap “Buy” — even for the tiniest fractional share.

Despite its fame, the TASER brand is massively under-penetrated internationally.

Across the last decade, Axon’s non-U.S. revenue has floated between 14% and 21%. That means about 80–85% of the business is still in the United States.

Roughly:

• 2015–2021: often around 18–21% international
• 2023: 14%
• 2024: 15%

Translation?
Axon has barely begun selling the TASER brand to the rest of the world.

Yes, they have established customers — the UK, Australia, France, Singapore, Canada, plus bits of Latin America, Europe, and Asia — but this is still a thin slice of global law-enforcement markets.

The word TASER is known everywhere.
But it’s sold in far fewer places.

That gap is the opportunity.

---

💵 Why This Justifies My Tiny $100 Buy

I’m under no illusion: my $100 buys me something like 0.18% of one Axon share. It is financially microscopic.

But symbolically? It feels smart.

Axon is not a commodity business. It is a brand-plus-technology business. And the TASER name is an asset with:

• massive recognition
• strong legal protection
• decades of institutional trust
• enormous international runway
• defensibility competitors would kill for

So my little $100 buy is basically a bet on this sentence:

“TASER belongs to Axon — and the world still hasn’t bought enough of it.”

---

📝 Verdict (BUY / SELL / KEEP)

BUY (tiny, symbolic, long-term)

I wouldn’t build a full portfolio around Axon at current valuations, but owning even a sliver feels like owning a fraction of one of the most durable law-enforcement trademarks on Earth.

Sometimes you buy the numbers.
Sometimes you buy the story.
Today I bought the word.

Surprisingly, the answer is: not as much as you might expect.

🔢 International Revenue: 10-Year Trend

Here’s the share of Axon’s annual net sales generated outside the U.S. over the past decade:

Year	% of Revenue from Outside the U.S.
2015	18.2%
2016	18.4%
2017	17.7%
2018	20.2%
2019	16.0%
2020	21.0%
2021	20.0%
2022	17.0%
2023	14.0%
2024	15.0%

Key takeaway: Axon consistently earns 14–21% of its revenue from international markets. The remaining ~80–85% comes from U.S. customers.

While there was a peak around 2020–2021, the international share has drifted lower in the past few years — even as the company emphasizes global expansion.

🌍 Which Countries Contribute?

Axon’s SEC filings don’t break out revenue by country (only U.S. vs. “Other Countries”), but based on disclosures, press releases, government tenders, and historical contract data, the following regions account for most non-U.S. sales:

Major Known International Markets

• United Kingdom
• Australia
• France
• Singapore
• Canada

Growing Markets (Americas Region)

Axon reports that recent international revenue growth comes primarily from the Americas outside the U.S., which generally includes:

• Mexico
• Central America
• South America

Additional Countries Where Axon Has Publicly Documented Customers

(through tenders, agency announcements, or distributor listings)

• Germany
• Netherlands
• Belgium
• Sweden
• Norway
• New Zealand
• United Arab Emirates
• Qatar
• Saudi Arabia
• South Korea
• Japan

This is not an exhaustive list — Axon equipment is used in over 100 countries — but these are the markets with the clearest public evidence of commercial activity.

📈 What This Means for Investors

• Axon remains heavily U.S.-centric. Despite global ambitions, ~85% of revenue still comes from the domestic market.
• International growth is modest but stable, hovering around 15% of total sales.
• Upside potential lies in Latin America, Europe, and Asia, where digital policing adoption is accelerating.

For investors, this international mix suggests that Axon still has significant runway for expansion — but that the company’s financial performance remains tied mainly to U.S. public safety spending.